Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Aug 16, 2013

NEW YORK (GenomeWeb News) – Precision for Medicine has appointed Eric Perakslis to serve as senior advisor for bioinformatics and technology.

In his new role, Perakslis will provide strategic and scientific guidance on the development, acquisition, and execution of products and services.

He currently is executive director of the Center for Biomedical Informatics and the Francis A. Countway Library of Medicine at Harvard Medical School. Previously, he was chief information officer and chief scientist of informatics at the US Food and Drug Administration, and he worked in research IT and drug discovery at Johnson and Johnson.

Pathway Genomics has named Karl Odquist to be executive director of managed care. He will be responsible for managed care contracts and reimbursement, government affairs, and clinical evidence generation for the firm's diagnostic services.

Odquist has over 20 years of experience working with pharmaceutical payors and the medical benefits business, including working at Prometheus Laboratories.

Quanterix said this week that it has added Paul Meister to its board of directors. Meister is co-founder of Liberty Lane Partners, a private investment firm focused on healthcare and distribution-related businesses that acquired inVentiv Health, a provider of commercial, consulting, and clinical research services. He also is a former chairman of the board of Thermo Fisher Scientific.

Genomics data analysis developer Omixon said this week that it has named Tim Hague to take over as company CEO, and that company Founder, Chairman, CSO, and former CEO Attila Berces will continue to serve on the firm's board of directors.

Hague has worked in software engineering and design at Lufthansa Systems and as a technical team leader at IBM.

Cellular Dynamics International said this week that Michael Falk has resigned from his position on the company's board of directors for personal reasons. Falk is general counsel of the Wisconsin Alumni Research Foundation.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.